ZOETIS INC.
Ownership & governance
Executives 5Directors 10Avg age 62Avg tenure 7.5y
KP
Kristin Peck
Chief Executive Officer
Age 54Since 2019-12-31Profile →
+14
Executives5
KP
Kristin Peck→
Chief Executive Officer
Age 54Since 2019-12-31
WJ
Wetteny Joseph→
Director of Finance/CFO
Age 54Since 2021-05-31
KE
Kevin Esch→
Chief Tech/Sci/R&D Officer
Age 49Since 2025-12-31
JF
Julie Fuller→
Chief Operating Officer
Age 53Since 2024-07-31
RG
Richard Goldstein→
Chief Tech/Sci/R&D Officer
—Since 2024-03-20
Board of directors10
FD
Frank D'Amelio→
Director/Board Member
Age 68Since 2012-06-30
GN
Gregory Norden→
Director/Board Member
Age 68Since 2012-12-31
MM
Michael McCallister→
Chairman
Age 73Since 2013-06-25
SK
Sanjay Khosla→
Director/Board Member
Age 73Since 2013-05-31
WR
Willie Reed→
Director/Board Member
Age 71Since 2014-03-03
PB
Paul Bisaro→
Director/Board Member
Age 65Since 2015-04-30
KP
Kristin Peck→
Director/Board Member
Age 54Since 2019-10-01
AL
Antoinette Leatherberry→
Director/Board Member
Age 64Since 2020-12-07
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 6.394 % | 26,806,560 |
| Vanguard Capital Management LLC | 6.219 % | 26,072,846 |
| Vanguard Portfolio Management LLC | 5.717 % | 23,967,400 |
| STATE STREET CORPORATION | 4.61 % | 19,324,401 |
| State Farm Investment Management Corp. | 3.791 % | 15,892,903 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Julie Fuller | Chief Operating Officer | 2024-07-31 | - |
| Kevin Esch | Chief Tech/Sci/R&D Officer | 2025-12-31 | - |
| Kristin Peck | Chief Executive Officer | 2019-12-31 | - |
| Michael McCallister | Chairman | 2013-06-25 | - |
| Richard Goldstein | Chief Tech/Sci/R&D Officer | 2024-03-20 | - |
| Wetteny Joseph | Director of Finance/CFO | 2021-05-31 | - |
| Antoinette Leatherberry | Director/Board Member | 2020-12-07 | - |
| Frank D'Amelio | Director/Board Member | 2012-06-30 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Zoetis Treasury Center BV | — |
| Zoetis Ceská republika sro | Biotechnology |
| Zoetis Korea Ltd. | Pharmaceuticals: Major |
| Zoetis Philippines, Inc. | — |
| Pharmaq Vietnam Co. Ltd. | — |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 94.86Range 80–155Analysts 14
80Mean 94.86155
- Strong buy 3
- Buy 4
- Hold 10
Broker actions40 of 230
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | 94 | 2026-08-25 |
| Stifel | Maintained | Hold | 80 | 2026-08-20 |
| Citigroup | Maintained | Buy | 96 | 2026-08-11 |
| BNP Paribas | Maintained | Outperform | 110 | 2026-08-11 |
| Piper Sandler | Maintained | Neutral | 80 | 2026-08-10 |
| UBS | Maintained | Neutral | 80 | 2026-08-07 |
| JP Morgan | Maintained | Overweight | 115 | 2026-08-07 |
| William Blair | Downgrade | Market Perform | — | 2026-08-06 |
| UBS | Maintained | Neutral | 85 | 2026-07-27 |
| Morgan Stanley | Maintained | Overweight | 99 | 2026-07-22 |
| HSBC | Maintained | Buy | 95 | 2026-07-06 |
| Barclays | Maintained | Equal-Weight | 85 | 2026-07-01 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.